Tag: bortezomib
#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)
Check out the original article from the Lancet Haematology here.
#VisualAbstract CASSIOPEIA Part 1: Bortezomib, Thalidomide, and Dexamethasone with Daratumumab (D-VTd) May Improve Quality of Life Post-Consolidation in Newly Diagnosed, Transplantation-Eligible Multiple Myeloma (MM) Patients
Check out the original article from the Lancet Haematology here.
Weekly selinexor, bortezomib, and dexamethasone demonstrates improved survival in treatment-refractory multiple myeloma
1. A once-per-week regime of selinexor, bortezomib and dexamethasone was associated with significantly improved progression-free survival versus current standard of ...
![Improved hematologic cancer survival in Europe over a 15 year period [EUROCARE-5 study]](https://www.2minutemedicine.com/wp-content/uploads/2014/07/700px-Europe_polar_stereographic_Caucasus_Urals_boundary.svg_-350x250.png)
Improved hematologic cancer survival in Europe over a 15 year period [EUROCARE-5 study]
1. Survival improved for most types of hematologic malignancies in Europe between 1992 and 2007. 2. The improvements in survival ...
